Stereotactic body radiation therapy for gastrointestinal malignancies

Area of Science:

• Radiation Oncology
• Medical Physics
• Gastrointestinal Oncology

Background:

• Stereotactic body radiotherapy (SBRT) is an emerging technique for treating pancreas and liver tumors.
• Early data indicate high local control rates for SBRT in locally advanced pancreas cancer and liver tumors.
• Proximity of critical organs necessitates precise image guidance to mitigate treatment-related toxicities.

Purpose of the Study:

• To review the current status and potential of SBRT for pancreas and liver malignancies.
• To highlight the importance of minimizing dose to surrounding normal tissues and organs at risk.
• To identify areas for future research, including optimal fractionation and integration with systemic therapies.

Main Methods:

• Review of early clinical data and treatment considerations for SBRT in pancreas and liver cancer.
• Emphasis on image-guided techniques for accurate tumor targeting and organ sparing.
• Discussion of dose-response relationships and the need for standardized fractionation.

Main Results:

• SBRT demonstrates high local control rates for pancreas and liver tumors.
• Low risks of hepatic toxicity are observed in SBRT for liver tumors.
• Effective toxicity minimization requires careful case selection and precise image guidance.

Conclusions:

• SBRT is a viable treatment option for pancreas and liver tumors, offering excellent local control.
• Optimal SBRT strategies depend on lesion characteristics and require meticulous attention to normal tissue sparing.
• Further research is needed to establish standard fractionation schedules and synergistic combinations with chemotherapy.